Ignite Creation Date:
2024-05-05 @ 11:24 AM
Last Modification Date:
2024-10-26 @ 9:06 AM
Study NCT ID:
NCT00027053
Status:
COMPLETED
Last Update Posted:
2010-05-13
First Post:
2001-11-19
Brief Title:
Trazodone for Sleep Disturbance in Early Alcohol Recovery
Sponsor:
Rhode Island Hospital
Organization:
Rhode Island Hospital
Study Overview
Official Title:
Trazodone for Sleep Disturbance - Early Alcohol Recovery
Status:
COMPLETED
Status Verified Date:
2006-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
SIESTA
Brief Summary:
This study is a randomized double-blind clinical trial comparing trazodone Desyrel and placebo among sleep-disturbed alcohol-dependent individuals shortly after discharge from an inpatient detoxification program Subjects will undergo a baseline assessment and random assignment to trazodone or identical placebo for 12 weeks All persons completing the alcohol detoxification at Stanley Street Treatment and Resources SSTAR will be screened SSTAR of Rhode Island provides detoxification services to nonunderinsured persons of Rhode Island
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| NIH grant R01 AA013243 | US NIH GrantContract | None | httpsreporternihgovquickSearchR01AA013243 |
| R01AA013243 | NIH | None | None |